These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 17479394)

  • 1. Interaction index and different methods for determining drug interaction in combination therapy.
    Lee JJ; Kong M; Ayers GD; Lotan R
    J Biopharm Stat; 2007; 17(3):461-80. PubMed ID: 17479394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying synergism/antagonism using nonlinear mixed-effects modeling: a simulation study.
    Boik JC; Newman RA; Boik RJ
    Stat Med; 2008 Mar; 27(7):1040-61. PubMed ID: 17768754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A generalized response surface model with varying relative potency for assessing drug interaction.
    Kong M; Lee JJ
    Biometrics; 2006 Dec; 62(4):986-95. PubMed ID: 17156272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallel dose-response curves in combination experiments.
    Sühnel J
    Bull Math Biol; 1998 Mar; 60(2):197-213. PubMed ID: 9559575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fitting models for the joint action of two drugs using SAS.
    Whitehead A; Whitehead J; Todd S; Zhou Y; Smith MK
    Pharm Stat; 2008; 7(4):272-84. PubMed ID: 17979217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confidence Intervals of Interaction Index for Assessing Multiple Drug Interaction.
    Lee JJ; Kong M
    Stat Biopharm Res; 2009 Feb; 1(1):4-17. PubMed ID: 20037663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and sample size for evaluating combinations of drugs of linear and loglinear dose-response curves.
    Fang HB; Tian GL; Li W; Tan M
    J Biopharm Stat; 2009 Jul; 19(4):625-40. PubMed ID: 20183430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mathematical formulation of additivity for antimicrobial agents.
    Boucher AN; Tam VH
    Diagn Microbiol Infect Dis; 2006 Aug; 55(4):319-25. PubMed ID: 16626903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mathematical approach to study combined effects of toxicants in vitro: evaluation of the Bliss independence criterion and the Loewe additivity model.
    Goldoni M; Johansson C
    Toxicol In Vitro; 2007 Aug; 21(5):759-69. PubMed ID: 17420112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards a mechanism-based analysis of pharmacodynamic drug-drug interactions in vivo.
    Jonker DM; Visser SA; van der Graaf PH; Voskuyl RA; Danhof M
    Pharmacol Ther; 2005 Apr; 106(1):1-18. PubMed ID: 15781119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental design and interaction analysis of combination studies of drugs with log-linear dose responses.
    Fang HB; Ross DD; Sausville E; Tan M
    Stat Med; 2008 Jul; 27(16):3071-83. PubMed ID: 18186545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response or dose-effect curves in in vitro experiments and their use to study combined effects of neurotoxicants.
    Goldoni M; Tagliaferri S
    Methods Mol Biol; 2011; 758():415-34. PubMed ID: 21815082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple test for synergy for a small number of combinations.
    Novick SJ
    Stat Med; 2013 Dec; 32(29):5145-55. PubMed ID: 23904140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The concentration-dependent nature of in vitro amphotericin B-itraconazole interaction against Aspergillus fumigatus: isobolographic and response surface analysis of complex pharmacodynamic interactions.
    Meletiadis J; te Dorsthorst DT; Verweij PE
    Int J Antimicrob Agents; 2006 Nov; 28(5):439-49. PubMed ID: 17055706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating response to antineoplastic drug combinations in tissue culture models.
    Reynolds CP; Maurer BJ
    Methods Mol Med; 2005; 110():173-83. PubMed ID: 15901935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonlinear statistical models for the joint action of toxins.
    Barton CN; Braunberg RC; Friedman L
    Biometrics; 1993 Mar; 49(1):95-105. PubMed ID: 8513113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of cytotoxic agents: a rule-based system for computer-assisted cell survival analysis.
    Gentile FP; Chiatti L; Mauro F; Briganti G; Floridi A; Benassi M
    Anticancer Res; 1992; 12(3):637-43. PubMed ID: 1622119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical analysis of drug interactions.
    Mitchell CL
    NIDA Res Monogr; 1986; 68():41-64. PubMed ID: 3095655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico synergism and antagonism of an anti-tumour system intervened by coupling immunotherapy and chemotherapy: a mathematical modelling approach.
    Hu WY; Zhong WR; Wang FH; Li L; Shao YZ
    Bull Math Biol; 2012 Feb; 74(2):434-52. PubMed ID: 21972030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.